Nanology Labs Secures $3 Million in Oversubscribed Seed Round

Ontario Industry Updates
Written By Viktoriya Shabat
Nanology Labs.PNG

Nanology Labs, an IND-stage company developing next generation nanomedicines to conquer cancer, announced, on May 17, that its seed capital raise was oversubscribed at $3M. The round was led by FACIT with co-investors Creative Destruction Lab Angels, Ontario Brain Institute, Ontario Center of Innovation, and MEDTEQ.

Viktoriya Shabat
Previous

Microbix Announces Closing of Offering and Private Placement - $6.9 Million of Gross Proceeds Received
Next

KA Imaging Installs Two New Mobile X-Ray Units at University Health Network